GB1483837A - Polypeptide hormone - Google Patents

Polypeptide hormone

Info

Publication number
GB1483837A
GB1483837A GB11285/75A GB1128575A GB1483837A GB 1483837 A GB1483837 A GB 1483837A GB 11285/75 A GB11285/75 A GB 11285/75A GB 1128575 A GB1128575 A GB 1128575A GB 1483837 A GB1483837 A GB 1483837A
Authority
GB
United Kingdom
Prior art keywords
molecular
march
binding
hormone
cellulose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB11285/75A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HAMBURGER J
Original Assignee
HAMBURGER J
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HAMBURGER J filed Critical HAMBURGER J
Publication of GB1483837A publication Critical patent/GB1483837A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C07K4/12—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/837—Lymph; lymph-glands; thymus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
GB11285/75A 1974-03-25 1975-03-18 Polypeptide hormone Expired GB1483837A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45449374A 1974-03-25 1974-03-25

Publications (1)

Publication Number Publication Date
GB1483837A true GB1483837A (en) 1977-08-24

Family

ID=23804832

Family Applications (1)

Application Number Title Priority Date Filing Date
GB11285/75A Expired GB1483837A (en) 1974-03-25 1975-03-18 Polypeptide hormone

Country Status (5)

Country Link
US (1) US4133804A (cg-RX-API-DMAC7.html)
DE (1) DE2512975A1 (cg-RX-API-DMAC7.html)
FR (1) FR2265404B1 (cg-RX-API-DMAC7.html)
GB (1) GB1483837A (cg-RX-API-DMAC7.html)
NL (1) NL7502830A (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1114943B (it) * 1977-12-27 1986-02-03 Sclavo Inst Sieroterapeut Processo per la preparazione di somatomammotropina corionica umana
JPS5852225A (ja) * 1981-09-22 1983-03-28 Mitsui Pharmaceut Inc 脱髄疾患治療剤
IL69686A (en) * 1983-09-11 1988-03-31 Yeda Res & Dev Compositions containing cell membrane proteins and process for their preparation
US4621135A (en) * 1983-12-08 1986-11-04 Yeda Research & Development Company, Ltd. Novel THF compositions
EP0149468B1 (de) * 1984-01-12 1990-10-31 SYMBIOTEC Gesellschaft zur Forschung und Entwicklung auf dem Gebiet der Biotechnologie GmbH Biologisch wirksame Substanz mit hormonellen Eigenschaften, Verfahren zu ihrer Herstellung und Verwendung von Histonen für medizinische Zwecke
US4814434A (en) * 1984-02-03 1989-03-21 Ventres Laboratories, Inc. Inducer of T-suppressor cells
IT1209955B (it) * 1985-05-03 1989-08-30 Serono Ist Farm Trattamento di malattie parassitiche
US5728680A (en) 1987-12-30 1998-03-17 Cytoven J.V. Methods for normalizing numbers of lymphocytes
US5807830A (en) * 1987-12-30 1998-09-15 Cytoven J.V. Method for treatment of purulent inflammatory diseases
US5811399A (en) * 1988-12-14 1998-09-22 Cytran, Inc. Pharmaceutical dipeptide compositions and methods of use thereof: immunodepressants
US5770576A (en) * 1989-08-30 1998-06-23 Cytran, Inc. Pharmaceutical dipeptide compositions and methods of use thereof: systemic toxicity
US6066622A (en) * 1991-10-28 2000-05-23 Cytran, Inc. Immunomodulating peptides and methods of use
US6100380A (en) * 1991-10-28 2000-08-08 Cytran, Inc. Immunomodulating peptides and methods of use
US7682818B2 (en) * 2003-03-28 2010-03-23 Fujifilm Corporation Apparatus for separating and purifying nucleic acid and method for separating and purifying nucleic acid
FR2930156B1 (fr) * 2008-04-21 2011-10-28 Cll Pharma Utilisation du nonapeptide pat dans le traitement des maladies autoimmunes.
MX339762B (es) 2011-09-28 2016-05-27 Univ Autonoma Del Estado De Morelos Metalopeptidos inmunomoduladores (immp) y composiciones que los contienen.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4010148A (en) * 1975-05-12 1977-03-01 Board Of Regents Of The University Of Texas System Purified thymosin and process

Also Published As

Publication number Publication date
NL7502830A (nl) 1975-09-29
DE2512975A1 (de) 1975-10-09
FR2265404A1 (cg-RX-API-DMAC7.html) 1975-10-24
US4133804A (en) 1979-01-09
FR2265404B1 (cg-RX-API-DMAC7.html) 1979-06-08

Similar Documents

Publication Publication Date Title
Haber et al. Synthesis of antigenic branch-chain copolymers of angiotensin and poly-L-lysine
Stein et al. Phenylacetylglutamine as a constituent of normal human urine
Shidoji et al. Vitamin A transport in plasma of the non-mammalian vertebrates: isolation and partial characterization of piscine retinol-binding protein 1
Gårdlund et al. Primary Structure of Human Fibrinogen: Characterization of Disulfide‐Containing Cyanogen‐Bromide Fragments
GB1364497A (en) Therapeutically useful polypeptides
Olson et al. Localization of phosphoprotein C23 in nucleoli by immunological methods
Davison Chromatography of histones
Javaid et al. Association of glycoproteins with the membranes. I. Isolation and molecular weight of the monomeric unit of the major glycoprotein from human erythrocytes
Rudman et al. Isolation of two lipolytic pituitary peptides
Lowy et al. Preparation of N-Substituted 1-Amino-1-deoxy-D-arabino-hexuloses1 of Arginine, Histidine and Lysine. 2 II
Jarvis et al. The Synthesis of 1-(Hemi-homocystine)-oxytocin and A Study of Some of its Pharmacological Properties1
Tavares-Almeida et al. Aromatic amino acid metabolites as potential protein binding inhibitors in human uremic plasma
ES401556A1 (es) Un procedimiento para mejorar el aroma a queso madurado de una composicion alimenticia.
IL43751A (en) Des-lys29-ala30-insulins and their preparation
原野恵子 et al. Mapping and amino acid analysis of tryptic peptides of globin by use of cellulose thin layer
Nagata et al. Distribution of the low molecular weight form of eukaryotic elongation factor 1 in various tissues
Katsoyannis et al. Insulin peptides. XXI. Synthesis of the B chain of sheep (bovine, porcine) insulin and its isolation as the S-sulfonated derivative
Poffenbarger et al. The nature of human serum insulin-like activity (ILA): characterization of ILA in serum and serum fractions obtained by acid-ethanol extraction and adsorption chromatography
Swartz et al. Binding of estrogens by α-fetoprotein in rat amniotic fluid
Zahn et al. Fractionation of the chymotryptic precipitate of Bombyx mori silk fibroin
GB1514049A (en) Cross-linked orgotein
Watkins Neurophysins of the human pituitary gland
Kageyama et al. The carbohydrate moiety of Japanese monkey pepsinogens. Its composition and site of attachment to protein
Katsoyannis et al. Insulin peptides. XXII. Synthesis of the human insulin B-chain S-sulfonate
Molina et al. Effect of vasopressin and dehydration on protein-bound sulfhydryl and disulfide groups in renal cells

Legal Events

Date Code Title Description
429A Application made for amendment of specification (sect. 29/1949)
429H Application (made) for amendment of specification now open to opposition (sect. 29/1949)
429D Case decided by the comptroller ** specification amended (sect. 29/1949)
PS Patent sealed [section 19, patents act 1949]
SP Amendment (slips) printed
732 Registration of transactions, instruments or events in the register (sect. 32/1977)
PCNP Patent ceased through non-payment of renewal fee